维普中文期刊产品整合服务
9篇 您的检索式:作者名="Marcom P"
    题名 作者 年代 出处 被引量
1TBCRC001: ran- domized phase II study of cetuximab in combination with carbo- platin in stage IV triple-negative breast cancer显示文摘Carey L A Rugo H S Marcom P K 2012J Clin On- col2012,30,21:1
2TBCRC 001:EGFR inhibition with cetuximab added to carboplatin in metastatic triple-negative(basal-like)breast cancer(abstract 1009)显示文摘CAREY L A RUGO H S MARCOM P K 2008J Clin Oncol2008,26,:1
3TBCRC 001:EGFR inhibition with cetuximab added to carboplatin in metastatic triple-negative (basal-like) breast cancer显示文摘Carey L A Rugo H S Marcom P 0,,15:1
4TBCRC 001:randomized phase Ⅱ study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer显示文摘Carey L A Rugo H S Marcom P K 0,,21:1
5TBCRC 001 :EGFR inhibition with cetuximab added to carboplain in metastatic triple-negative (basal-like) breast cancer显示文摘Carey L Rugo H Marcom P 2008J Clin Oncol2008,26,15:1
6TBCRC 001 : EGFR inhibition with eetuximab in metastatic triple negative ( basal -like) breast cancer显示文摘CAREY L A MAYER E MARCOM P K 2007Breast Cancer Res Treat2007,106,1:1
7Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840 显示文摘Seidman AD Berry D Cirrincione C Harris L Muss H Marcom PK Gipson G Burstein H Lake D Shapiro CL Ungaro P Norton L Winer E Hudis C 2008J Clin Oncol2008,6,10:1
8Validationoftwoimmunoassaymethodsforenvironmentalmonitoringofcarbaryland1naphtholingroundwatersamples显示文摘MARCOM P CHIRONS GASCONJG etal 1995AnalyticaChimicaActa1995,311,3:1
9Synthesis of haptens and conjugates for an enzyme immunoassay for analysis of the herbicide bromacil显示文摘Szurdoki F BekheitH K M MarcoM P 1992J Agric Food Chem1992,40,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费